ATC code C08: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
{{Editor Join}} | {{Editor Join}} | ||
__NOTOC__ | |||
A section of the [[Anatomical Therapeutic Chemical Classification System]]. | A section of the [[Anatomical Therapeutic Chemical Classification System]]. | ||
Revision as of 21:08, 22 April 2009
WikiDoc Resources for ATC code C08 |
Articles |
---|
Most recent articles on ATC code C08 Most cited articles on ATC code C08 |
Media |
Powerpoint slides on ATC code C08 |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on ATC code C08 at Clinical Trials.gov Clinical Trials on ATC code C08 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on ATC code C08
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on ATC code C08 Discussion groups on ATC code C08 Patient Handouts on ATC code C08 Directions to Hospitals Treating ATC code C08 Risk calculators and risk factors for ATC code C08
|
Healthcare Provider Resources |
Causes & Risk Factors for ATC code C08 |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
A section of the Anatomical Therapeutic Chemical Classification System.
C08C Selective calcium channel blockers with mainly vascular effects
C08CA Dihydropyridine derivatives
- C08CA01 Amlodipine
- C08CA02 Felodipine
- C08CA03 Isradipine
- C08CA04 Nicardipine
- C08CA05 Nifedipine
- C08CA06 Nimodipine
- C08CA07 Nisoldipine
- C08CA08 Nitrendipine
- C08CA09 Lacidipine
- C08CA10 Nilvadipine
- C08CA11 Manidipine
- C08CA12 Barnidipine
- C08CA13 Lercanidipine
- C08CA14 Cilnidipine
- C08CA15 Benidipine
- C08CA55 Nifedipine, combinations
C08CX Other selective calcium channel blockers with mainly vascular effects
- C08CX01 Mibefradil
C08D Selective calcium channel blockers with direct cardiac effects
C08DA Phenylalkylamine derivatives
- C08DA01 Verapamil
- C08DA02 Gallopamil
- C08DA51 Verapamil, combinations
C08DB Benzothiazepine derivatives
- C08DB01 Diltiazem
C08E Non-selective calcium channel blockers
C08EA Phenylalkylamine derivatives
- C08EA01 Fendiline
- C08EA02 Bepridil
C08EX Other non-selective calcium channel blockers
- C08EX01 Lidoflazine
- C08EX02 Perhexiline
C08G Calcium channel blockers and diuretics
C08GA Calcium channel blockers and diuretics
- C08GA01 Nifedipine and diuretics